Sequana Medical NV (SEQUA.BR)

EUR 0.72

(3.43%)

Market Cap (In EUR)

32.17 Million

Revenue (In EUR)

712.17 Thousand

Net Income (In EUR)

-32.56 Million

Avg. Volume

29.69 Thousand

Currency
EUR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.471-4.85
PE
-
EPS
-
Beta Value
0.854
ISIN
BE0974340722
CUSIP
B7T4AP107
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Ian Crosbie
Employee Count
-
Website
https://www.sequanamedical.com
Ipo Date
2019-02-11
Details
Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.